{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T07:10:19Z","timestamp":1756278619609,"version":"3.44.0"},"reference-count":22,"publisher":"BMJ","issue":"11","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2022,6,20]]},"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:p>Familial amyloidosis of the Finnish type (FAF) is a rare multisystemic disorder caused by mutations in the gelsolin gene. The clinical presentation is typically characterised by a triad of ophthalmic, neurological and dermatological findings. FAF has been reported in several countries, primarily in Finland and recently in Portugal. We report the first genetically confirmed cases of FAF from two unrelated families in our neuromuscular outpatient clinic. Gelsolin gene sequencing revealed the heterozygous gelsolin mutation (c.640G&gt;A). The clinical features and the neurophysiological studies of two index patients and their relatives are presented. Obtaining an early diagnosis can be challenging, but FAF should be considered in the differential diagnosis of progressive bilateral facial neuropathy, even if there is no known Finnish ancestor.<\/jats:p>","DOI":"10.1136\/bcr-2021-245764","type":"journal-article","created":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T11:34:26Z","timestamp":1668512066000},"page":"e245764","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Familial amyloidosis of the Finnish type: clinical and neurophysiological features of two index cases"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7921-8341","authenticated-orcid":false,"given":"In\u00eas","family":"Antunes Cunha","sequence":"first","affiliation":[{"name":"Neurology Deparment, Centro Hospitalar e Universitario de Coimbra EPE, Coimbra, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Br\u00e1s","sequence":"additional","affiliation":[{"name":"Neurology Deparment, Centro Hospitalar e Universitario de Coimbra EPE, Coimbra, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F\u00e1tima","family":"Silva","sequence":"additional","affiliation":[{"name":"Neurology Deparment, Centro Hospitalar e Universitario de Coimbra EPE, Coimbra, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anabela","family":"Matos","sequence":"additional","affiliation":[{"name":"Neurology Deparment, Centro Hospitalar e Universitario de Coimbra EPE, Coimbra, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,11,15]]},"reference":[{"key":"2025082623422317000_15.11.e245764.1","doi-asserted-by":"publisher","DOI":"10.1080\/13506129.2020.1835263"},{"key":"2025082623422317000_15.11.e245764.2","first-page":"314","article-title":"Familial systemic paramyloidosis with lattice dystrophy of the cornea, progressive neuropathy, skin changes and various internal symptoms","volume":"1","author":"Meretoja","year":"1969","journal-title":"Ann Clin Res"},{"key":"2025082623422317000_15.11.e245764.3","doi-asserted-by":"publisher","DOI":"10.1038\/ng1192-204"},{"key":"2025082623422317000_15.11.e245764.4","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2012.07.016"},{"key":"2025082623422317000_15.11.e245764.5","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3109\/13506129.2014.891502","article-title":"Novel gelsolin variant as the cause of nephrotic syndrome and renal amyloidosis in a large kindred","volume":"21","author":"Efebera","year":"2014","journal-title":"Amyloid"},{"key":"2025082623422317000_15.11.e245764.6","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.mayocp.2018.06.016","article-title":"A patient with hereditary ATTR and a novel AGel p.Ala578Pro amyloidosis","volume":"93","author":"Sridharan","year":"2018","journal-title":"Mayo Clin Proc"},{"key":"2025082623422317000_15.11.e245764.7","first-page":"345","article-title":"Clinical, histopathological, and in silico pathogenicity analyses in a pedigree with familial amyloidosis of the Finnish type (Meretoja syndrome) caused by a novel gelsolin mutation","volume":"26","author":"Cabral-Macias","year":"2020","journal-title":"Mol Vis"},{"key":"2025082623422317000_15.11.e245764.8","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22031084","article-title":"Clinical and Histopathological Features of Gelsolin Amyloidosis Associated with a Novel GSN Variant p.Glu580Lys","volume":"22","author":"Potr\u010d","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2025082623422317000_15.11.e245764.9","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/B978-0-444-52902-2.00039-4","article-title":"Hereditary gelsolin amyloidosis","volume":"115","author":"Kiuru-Enari","year":"2013","journal-title":"Handb Clin Neurol"},{"key":"2025082623422317000_15.11.e245764.10","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1399-0004.1973.tb01140.x","article-title":"Genetic aspects of familial amyloidosis with corneal lattice dystrophy and cranial neuropathy","volume":"4","author":"Meretoja","year":"1973","journal-title":"Clin Genet"},{"key":"2025082623422317000_15.11.e245764.11","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.84.4.390"},{"key":"2025082623422317000_15.11.e245764.12","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1159\/000479729","article-title":"The first Argentinian family with familial amyloidosis of the Finnish type","volume":"8","author":"Lucero Sa\u00e1","year":"2017","journal-title":"Case Rep Ophthalmol"},{"key":"2025082623422317000_15.11.e245764.13","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1590\/S0004-27492011000400012","article-title":"Danish type gelsolin-related amyloidosis in a Brazilian family: case reports","volume":"74","author":"Solari","year":"2011","journal-title":"Arq Bras Oftalmol"},{"key":"2025082623422317000_15.11.e245764.14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/jns.12200","article-title":"Hereditary gelsolin amyloidosis (HGA): a neglected cause of bilateral progressive or recurrent facial palsy","volume":"22","author":"Sagnelli","year":"2017","journal-title":"J Peripher Nerv Syst"},{"key":"2025082623422317000_15.11.e245764.15","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1017\/cjn.2015.56","article-title":"Gelsolin familial amyloidosis peripheral neuropathy in Canada: a case report","volume":"42","author":"Alabdali","year":"2015","journal-title":"Can J Neurol Sci"},{"key":"2025082623422317000_15.11.e245764.16","doi-asserted-by":"publisher","DOI":"10.1002\/mus.10474"},{"key":"2025082623422317000_15.11.e245764.17","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-020-1300-5","article-title":"Finnish gelsolin amyloidosis causes significant disease burden but does not affect survival: FIN-GAR phase II study","volume":"15","author":"Schmidt","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"2025082623422317000_15.11.e245764.18","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1755-3768.2009.01686.x","article-title":"Lattice corneal dystrophy, gelsolin type (Meretoja's syndrome)","volume":"87","author":"Carrwik","year":"2009","journal-title":"Acta Ophthalmol"},{"key":"2025082623422317000_15.11.e245764.19","doi-asserted-by":"publisher","DOI":"10.1080\/13506120601116393"},{"key":"2025082623422317000_15.11.e245764.20","doi-asserted-by":"publisher","DOI":"10.1002\/mus.880170307"},{"key":"2025082623422317000_15.11.e245764.21","doi-asserted-by":"publisher","DOI":"10.3109\/10409238.2012.661401"},{"key":"2025082623422317000_15.11.e245764.22","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(199903)45:3<305::AID-ANA5>3.0.CO;2-E"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2021-245764","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T06:42:37Z","timestamp":1756276957000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2021-245764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":22,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11,15]]},"published-print":{"date-parts":[[2022,11]]}},"alternative-id":["10.1136\/bcr-2021-245764"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2021-245764","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2022,11]]}}}